HIV prevention among injecting drug users: responses in developing and transitional countries

Area of Science:

• Public Health
• Infectious Diseases
• Epidemiology

Background:

• Injecting drug use is a major driver of the global human immunodeficiency virus (HIV) epidemic, affecting at least 98 countries.
• Emerging HIV epidemics associated with injecting drug use are evident in regions like Eastern Europe, Latin America, and the eastern Mediterranean.
• There is a critical need for understanding the scope and response to HIV among injecting drug users (IDUs) in developing and transitional countries.

Purpose of the Study:

• To provide a comprehensive global overview of the HIV infection situation among injecting drug users.
• To document the range of HIV prevention strategies implemented in developing and transitional countries.
• To highlight innovative approaches to HIV prevention tailored to local needs.

Main Methods:

• Compilation of data from diverse sources including published literature, gray literature, and international organizations (WHO, UNAIDS, UNDCP).
• Inclusion of information from personal communications and direct author observations.
• Extensive travel and information gathering in developing and transitional countries to access non-public data.

Main Results:

• A variety of HIV prevention strategies targeting injecting drug users (IDUs) are being implemented in developing and transitional countries.
• Interventions include opioid substitution pharmacotherapy, needle and syringe programs, condom and bleach distribution, and outreach.
• Novel intervention models have been developed in response to specific local needs and resource limitations.

Conclusions:

• Despite potential limitations in empirical data on effectiveness, innovative HIV prevention initiatives are being implemented and sustained.
• These initiatives demonstrate adaptability across diverse sociocultural settings.
• Continued efforts are crucial for addressing the HIV epidemic among IDUs in resource-limited settings.